Canary Capital lists first staked Injective ETF on Nasdaq
Alpha Vantage · Cryptonews.net · · AI-summarised by FinFlash
Canary Capital has launched the first US-listed staked spot Injective ETF on Nasdaq under ticker INJC. Carrying a 1.10% annual fee, the fund stakes at least 90% of its holdings to generate network yield. This gives investors a regulated brokerage vehicle to access staking returns directly alongside spot INJ token exposure.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.